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Abstract 
 
Amyloidosis, which involves the precipitation of mis-folded protein aggregates, is 
a prominent process that occurs in many neurodegenerative conditions such as 
Alzheimer's disease and Parkinson's disease; the protein aggregates being amyloid-β for 
Alzheimer’s disease and α-synuclein for Parkinson’s disease. This study has focused on 
lysozyme modifications induced by metabolites of the commonly found pollutants known 
as polycyclic aromatic hydrocarbons (PAHs). PAHs are found in substances ranging from 
grilled meats to cigarette smoke to cosmetics, and they can be metabolized into a family 
of biological toxins known as benzoquinones. The molecules of interest for this study 
were 1,4-benzoquinone (pBQ), 2-chloro-1,4-benzoquinone (CBQ), and 2-methyl-1,4-
benzoquinone (MBQ). The effect these benzoquinones had on lysozyme was studied by 
first creating samples through time- and concentration-dependent incubations in 
physiologic conditions. These samples were then examined through SDS-PAGE analysis, 
fluorescence assays, and UV-Vis spectroscopy to determine the products created through 
this modification. Our findings revealed the effective oligomerization and aggregation of 
lysozyme modified by benzoquinones. 
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Glossary 
APS ................................................................................................... Ammonium Persulfate 
Ar ......................................................................................................................... Argon Gas 
CBQ  ........................................................................................ 2-Chloro-1,4-Benzoquinone 
Da .................................................................................................... Dalton (equal to 1 amu) 
EtOH ............................................................................................... Ethanol (Ethyl Alcohol) 
hr ................................................................................................................................... Hour 
kDa ...................................................................................... Kilodalton (equal to 1000 amu) 
Lys............................................................................................................................... Lysine 
MBQ ........................................................................................ 2-Methyl-1,4-Benzoquinone 
MeOH ....................................................................................... Methanol (Methyl Alcohol) 
Min ............................................................................................................................. Minute 
PAH................................................................................ Polycyclic Aromatic Hydrocarbon 
PBQ .......................................................................................................... 1,4-Benzoquinone 
RNase ............................................................................................................... Ribonuclease 
ROS ............................................................................................... Reactive Oxygen Species 
SDS ................................................................................................ Sodium Dodecyl Sulfate 
SDS-PAGE  ........................ Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
TEMED ............................................................. N,N,N’,N’-tetramethyl-ethane-1,2-diamide 
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Chapter I 
Introduction 
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In 1854, the physician-scientist Rudolph Virchow introduced the term amyloid to 
describe necrotic plaques (Figure I) seen in the cerebral corpora amylacea of some of his 
patients [1]. Virchow wrongly concluded that the substance must be made of cellulose, 
but it was determined to be a protein structure in 1859, and thus the study of the 
pathology of protein mis-folding and modification came into existence [1]. Over a 
hundred and fifty years later, amyloids and amyloidogenesis, a process in which the 
secondary conformations of a protein changes into pleated β-sheets, resulting in self-
aggregation into precipitated (and often necrotic) plaques, are known to play a central 
role in several prominent and crippling neurodegenerative conditions such as Alzheimer’s 
disease and Parkinson’s disease [2-4].  
 
 
Figure 1.1: Amyloidal deposits in cellular samples at low magnification [1] 
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Proteins are essential to all organisms, eukaryotes and prokaryotes alike, and 
interruption of their normal functions can be very detrimental to life at the cellular level 
[5]. Proteins can be modified by a number of factors, from genetic errors, to translational 
and post-translational modifications, to toxicological and chemical modifications by 
environmental factors [5-10]. Because of this, proteopathies, pathological mis-folding 
and aberrant polymerization of proteins, have become central in the study of many 
cerebral and neurological diseases because their causes are often very difficult to 
elucidate or involve many pathological pathways [11-14].  One such area of study 
focuses on environmental toxicants and their subsequent effects on proteins and cellular 
functions [9, 10]. 
Polycyclic aromatic hydrocarbons (PAHs) are a prevalent class of environmental 
pollutants that can be produced by many industrial processes [9, 13, 14]. PAHs are 
characterized by condensed aromatic ring systems, and they are commonly found as 
environmental pollutants in the soil, atmosphere, and other sources that include cigarette 
smoke, diesel fuel, cosmetics, grilled foods, and in the disinfectants for public water 
supplies [9, 10, 13, 14]. PAHs are of concern because they can be metabolic precursors to 
cancer-causing molecules, as well as precursors to protein modifying molecules [9, 13-
15]. PAHs arise mostly from the partial or incomplete combustion of other hydrocarbons, 
which is a process that consumes hydrogen faster than carbon, so the carbon is left in the 
more thermodynamically stable state of an aromatic ring system [9, 10]. Benzo(a)pyrene 
is a commonly studied PAH because its partially oxidized and metabolized form is a 
strong carcinogen that can easily bind to DNA in humans and other animals [9]. A few 
common PAH and PAH-like molecules are displayed in Figure 1.2. 
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Figure 1.2: Common Polycyclic Aromatic Hydrocarbons 
 
  
PAHs exhibit their cytotoxicity through their metabolites, which are most often 
quinones in either their reduced and oxidized forms [13, 14]. Quinones can cause toxic 
damage to a cell through a variety of processes, including DNA modifications, oxidative 
damage, lipid modifications, and protein modifications [13-17]. PAHs begin their 
biological journey in the smooth endoplasmic reticulum of a cell, where they undergo an 
epoxidation reaction via the enzyme cytochrome P450 [5, 6, 13, 17-20]. Cytochrome 
P450 takes its name from its λmax at 450 nanometers, and it belongs to a superfamily of 
heme-containing enzymes that are found in almost all living organisms [5, 6]. From this 
point, a PAH can either spontaneously form a phenol or form a dihydrodiol via an 
enzyme called epoxide hydrolase [17-20]. The phenol can form a hydroquinone under 
biological conditions, while the dihydrodiol can undergo another enzyme catalyzed 
reaction via dihydrodiol dehydrogenase to form a diol [17-20]. The hydroquinone can 
spontaneously form a benzoquinone under physiological conditions, and this product is in 
equilibrium, whereas the diol undergoes a final enzymatic reaction with tyrosinase to also 
form a quinone [17-20]. Several quinones can arise from the metabolic processing of 
PAHs, and it is the quinones that exhibit the largest amount of toxicity to the organism 
Benzene Naphthalene Benzo(a)pyrene 
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[13-15, 17-21]. A stepwise mechanistic summary of the metabolism of PAHs into 
benzoquinones from benzene (the simplest PAH) is given in Figure 1.3. 
 
 
 
Figure 1.3: Metabolism of PAHs into Benzoquinones.  
    A) 1,4-hydroquione (HQ). B) 1,4-benzoquinone (PBQ) [13, 17] 
 
 The resulting benzoquinone from this metabolism is toxic and highly detrimental 
to a cell in a number of ways [13]. Quinones can exhibit their hazardous effects through 
cytotoxicity, immunotoxicity, and carcinogenesis [15]. Benzoquinones have long been 
studied for their effects on various biomolecules, especially polypeptides and nucleic 
acids [14, 18, 19, 22]. 1,4-benzoquinone (PBQ) has been shown to cause acute 
myelogenous leukemia, aplastic anemia, myelodysplasia, and immunotoxicity; and it is 
through this metabolite that benzene is thought to exhibit part of its toxicity [9, 13, 15, 
16, 22-24]. Benzoquinones are Michael acceptors, and it has long been observed that they 
can demonstrate their toxicity to DNA and proteins through alkylation of large 
biomolecules [13-15, 25]. Adduct formation by PBQ can involve multiple pathways, such 
as a cyclized diquinone-lysine adduct or an adduct of PBQ and glutamic acid [13, 17, 25-
27]. The most studied mechanism of benzoquinone toxicity, however, is through 
oxidative-reductive cycling, or simply redox cycling [13-15, 17, 28]. Benzoquinones are 
extremely active redox molecules in biological systems, and they can redox cycle with 
their semiquinone radicals (quinones being the oxidizing agent in the cycle), which can 
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then lead to the formation of reactive oxygen species (ROS) [13-17]. The ROS formed 
through redox cycling of benzoquinones can cause a massive oxidative stress in a cellular 
environment by reacting with DNA, lipids, and proteins to form oxidized 
macromolecules, as well as reacting with molecules in various signaling pathways to 
cause their activation, such as protein kinase C [15-19, 28, 29]. Both the process of 
adduct formation and redox cycling are thought to occur simultaneously with quinones in 
cellular environments [15]. A final pathway that can contribute to benzoquinones toxicity 
arises from the cross-linking of proteins, which directly affects the functionality and 
integrity of the polypeptide [13, 14, 17]. Figure 1.4 displays the three major pathways by 
which benzoquinones can affect cellular proteins.  
 
 
 
Figure 1.4: Proposed Mechanism of Quinone’s Action [13, 14, 17]. 
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Few studies have been performed on the particular area of protein cross-linking 
induced by PAH quinones, and it is this pathway that is the focus of this thesis. Protein 
cross-linking is thought to occur when a benzoquinone reacts with a lysine residue on a 
protein, resulting in a lysine oxidation, where the amine group is replaced with an 
aldehyde [13, 14]. This modified lysine, called allysine, can then react with an intact 
lysine residue on another protein, forming a covalent bond between the two [30-33]. This 
condensation of lysine and allysine is seen as a natural and normal process in the well-
known protein, collagen, but it can be a detrimental process if it occurs in some other 
proteins (Figure 1.5) [30-36].  
 
 
Figure 1.5: Condensation of Lysine and Allysine Residues [30-34]. 
 
If this cross-linking process continues, oligomerization of multiple proteins can 
occur, with the possibility of the formation polymeric aggregates [13, 14, 17].  Protein 
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aggregation, a process where multiple mis-folded proteins assemble into large 
accumulated groups, is a common event in biological systems [13, 37-40]. Protein 
aggregation and mis-folding have become of particular interest in recent years due to 
large amounts of scientific evidence associating the processes with neurodegenerative 
diseases [2, 4, 13, 14, 37, 41-44]. In particular, the process of amyloidosis, in which 
protein aggregates precipitate out of solution in the form of plaques, is central to current 
studies of both Alzheimer’s disease and Parkinson’s disease [4-6, 41-47]. Table 1.1 
displays several neurodegenerative diseases and their associated amyloidal and mis-
folded protein. 
 
Table 1.1: Neurodegenerative Diseases and Associated Proteins [4, 5, 48, 49]. 
Disease Protein 
Alzheimer's Disease Amyloid-β from APP 
Parkinson's Disease α-synuclein 
Huntington's Disease 
Huntingtin protein 
with polyglutamine 
expansion 
Amylotrophic Lateral 
Sclerosis 
Unknown 
 
 Because of its strong association with many human diseases and disorders, it is 
important to understand protein aggregation and mis-folding, especially that of the 
amyloidogenic types. This thesis attempts to study PAH-quinones as a potential 
environmental toxin that can contribute to protein aggregation. In order to study this 
effect, the model protein, lysozyme, was used. Lysozyme was chosen because its 
aggregation and its link to amyloidosis is well-researched [13, 38-40, 50-55].  
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The protein lysozyme is a model protein for protein chemistry and structural 
biology. This is due to the fact that lysozyme easily crystalizes and the crystals that it 
forms diffract very well [56]. In 1963, the complete primary structure of hen egg white 
lysozyme was elucidated [57]. Lysozyme became an important protein in the study of 
protein mis-folding and aggregation when it was shown that point mutations in human 
lysozyme correlated heavily with the hereditary disease non-neuropathic systematic 
amyloidosis [58]. Human lysozyme functions as an antibacterial agent that hydrolyses the 
glycosidic linkages between N-acetylmuramic acid and N-acetylglucosamine in Gram-
positive bacteria [59]. The structure of lysozyme is presented in Figure 1.6 with the lysine 
residues highlighted. The lysine residues are of particular interest due to the possibility of 
lysine-allysine bonds serving as a contributing factor of aggregation. 
 
 
Figure 1.6: Structure of Lysozyme with lysine residues labeled [60]. 
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Lysozyme was chosen not only because of its history as a model protein in studies 
of amyloidosis and protein aggregation, but also because of its similarities to 
ribonuclease A (RNase). RNase is similar in amino acid residue content to lysozyme, and 
our laboratory has performed studies with RNase previously. An important distinguishing 
factor, however, is that RNase is non-amyloidogenic, while lysozyme is amyloidogenic. 
The primary sequences of lysozyme and RNase are compared and contrasted in Figure 
1.7. 
 
 
 
Figure 1.7: Sequence comparison of RNase (a) and lysozyme (b) with the residues lysine, serine, 
threonine, and cysteine highlighted [61, 62]. 
 
 
Three PAH quinones are chosen to obtain a substituent gradient to monitor how 
various substituents affect protein cross-linking of lysozyme. The three chosen quinones 
are PBQ, 2-chloro-1,4-benzoquinone (CBQ), and 2-methyl-1,4-benzoquinone (MBQ). 
The quinones, the PAHs from which they are derived, and their chemical effects are 
shown in Table 1.2. The experiments consist of in vitro incubations of lysozyme with a 
benzoquinone in physiological conditions, in order to obtain samples in a time- and 
concentration- dependent manner. These samples will then be studied via SDS-PAGE to 
determine if cross-linking is occurring, and if so, to what extent. 
(a) (b) 
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Table 1.2: PAHs, PAH Quinones, and Relative Effects 
 
 
 
  
PAH PAH Quinone Effect
Benzene PBQ
Unsubstituted
Methylbenzene MBQ
Electron Donating
Chlorobenzene CBQ
Electron Withdrawing
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Chapter II 
Materials and Methods 
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2.1 Introduction to Experimentation 
 
This thesis attempts to understand the reaction between three benzoquinones and 
the protein lysozyme. To do so, an experimental protocol had to be created to be able to 
limit the variables affecting the results, and it had to be replicable and reasonable, as well. 
To observe the effects of this reaction, in vitro incubations at physiological conditions 
were used. All solutions for experimentation were created in lab. For this thesis, the 
primary method of analysis was SDS-PAGE, which is very common technique for 
separating proteins by molecular mass [1]. All chemical components of SDS-PAGE were 
created in lab. 
It is necessary to discuss these materials and methods in detail because errors in 
these procedures and steps propagate into errors in the finalized data. To obtain the most 
accurate results possible, great care must be taken during every step of the experimental 
process. It is for these reasons that the materials and methods are of great importance. 
Without the knowledge and understanding of the processes necessary for 
experimentation, data cannot be obtained or interpreted properly.  
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2.2 Reagents and Solutions 
 
General: 
For this project, all solutions were created from basic reagents. All chemicals 
have been purchased from Fisher Scientific™ and are of reagent quality unless specified 
otherwise. All water used in either the creation of solutions or in experiments was 
deionized water (dI-water). The water was purified by a Millipore™ system (Milli-Q).  
 
2.2.1 Solutions for Incubations 
 Several solutions had to be created in order to run the incubations of lysozyme 
and quinone. These include phosphate buffer (50 mM, pH 7.0), quinone stock solutions 
(PBQ, CBQ, and MBQ, respectively), phosphate-methanol buffer, and lysozyme stock 
solution.  
Phosphate buffer was made by first using the Henderson-Hasselbalch equation 
(shown in equation 1) to calculate the weights of monosodium phosphate (NaH2PO4) and 
disodium phosphate (Na2HPO4) needed to produce a 50 mM buffer at pH 7.0. 
 
                                             𝑝𝐻 = 𝑝𝐾𝑎 + 𝑙𝑜𝑔
[𝐵𝑎𝑠𝑒]
[𝐴𝑐𝑖𝑑]
                                                    (1) 
 
  NaH2PO4 and its conjugate base, Na2HPO4, were chosen because phosphoric acid 
has multiple dissociation constants with a pKa around 7.2 for NaH2PO4 [2]. By creating 
an equilibrium between NaH2PO4 and Na2HPO4, an effective buffer range can be 
obtained at pH 7.0. Phosphate buffer was used as the buffer for all of the reactions 
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because of its buffer range and because phosphates are commonly found in biological 
systems and used in biological experimentation [3]. Phosphate buffer was stored at 4 °C 
in glass media bottles. 
To make quinone stocks, the quinone of interest (PBQ, CBQ, or MBQ) was 
weighed and placed into a volumetric flask. Because of issues with solubility (mechanical 
agitation was not enough to solubilize the quinone in the phosphate buffer), the quinones 
were dissolved in 10% MeOH/ 90% phosphate buffer. 
Lysozyme stock solutions were prepared by careful weighing and transfer to a 
volumetric flask. The lysozyme was diluted to volume with phosphate buffer. The stock 
was then sealed in tubes with Ar gas and kept at -80 °C until use. The Ar gas and cold 
temperatures were utilized to prevent the degradation and oxidation of the lysozyme 
stock solutions. 
 
2.2.2 Solutions for SDS-PAGE 
 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) is a 
complicated technique that requires many solutions. Since SDS-PAGE experimentation is 
well established in protein studies, and protocols can easily be obtained. Only a brief 
overview of important solutions will be given. The protocol followed was from Kim and 
coworkers [4]. 
 The electrode buffering system was comprised of 
Tris(hydroxymethyl)aminomethane (Tris) base. The loading dye contained bromophenol 
blue as the dye and mercaptoethanol as a denaturing agent. The staining solution for the 
gels contained Coomassie Brilliant Blue G250. 
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2.3 SDS-PAGE 
 
SDS-PAGE is an analytical technique that employs the anionic detergent SDS to 
cause the separation of macromolecules by molecular weight through electrophoretic 
methods [3, 5]. It is an extremely valuable and effective tool used in biochemistry and 
cellular biology today. What separates SDS-PAGE from other polyacrylamide techniques 
is its use of the detergent SDS, which plays two important factors. First, SDS works to 
denature the tertiary structure of a protein [1, 3, 5]. Secondly, SDS applies a uniformly 
distributed negative charge across the protein [5].  
SDS is an amphiphilic molecule, meaning that it has both hydrophilic (coming 
from the sulfate head of the molecule) and hydrophobic properties (coming from the 
hydrocarbon tail) [6]. These properties of SDS allow it to disrupt the hydrophobic 
interactions that stabilize the tertiary structure of a protein [5]. The molecular structure of 
SDS is given in Figure 2.3.1. 
 
 
 
Figure 2.3.1. Chemical Structure of SDS 
 
SDS alone cannot fully break down and linearize the tertiary structure of many proteins 
because many proteins contain disulfide bonds, which are covalent bonds, making them 
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much stronger than hydrophobic interactions [1, 5]. To overcome the disulfide bonds, the 
chemical mercaptoethanol is used to break them. The molecular structure of 
mercaptoethanol is given in Figure 2.3.2. 
 
 
 
Figure 2.3.2. The chemical structure of mercaptoethanol 
 
By using a combination of SDS, heat denaturing, and mercaptoethanol, the tertiary 
structure of a protein can be reduced to a linearized chain.  
 The second important aspect of SDS is its negative charge. SDS binds to proteins 
in a ratio of about 1.4 grams of SDS per 1 gram of protein, which works out to be 
approximately one SDS molecule for every two amino acid residues on a protein [1, 5, 7-
9]. Because of this binding property, SDS applies an extremely large negative charge that 
masks the intrinsic charge of the protein being studied [5]. Because of the denaturing and 
electronic properties of SDS, the result is that proteins are all similar in shape and charge-
to-mass ratios, which means that SDS-PAGE separates proteins purely by molecular 
mass [1, 5]. 
 The mobility of a protein through the gel matrix should vary linearly with the 
logarithm of their masses, so the mass of a protein can be determined within 5 to 10% 
accuracy [5]. To obtain a comparison of molecular weights, a molecular marker is 
typically used. A molecular marker contains several proteins of known molecular mass 
that can be used to compare against unknowns [1]. 
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 The principle of the SDS-PAGE apparatus is primarily derived from the attraction 
of charges. In a typical setup (an example is displayed in Figure 2.3.3), a vertical gel is 
placed in a housing that contains electrically conductive buffer [1].  
 
 
Figure 2.3.3. Schematic illustration of an SDS-PAGE Gel [5, 10].  
 
There is a negative electrode (cathode) at the top, where the samples are loaded, and there 
is a positive electrode (anode) at the bottom. The samples are highly negative due to the 
SDS, which first dissociates from Na
+
, and then interacts with the linearized polypeptide 
chain [1]. The negatively charged proteins are attracted to the positive electrode at the 
bottom of the gel [1]. There are two gels in SDS-PAGE: there is the stacking gel and the 
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resolving or running gel. The stacking gel is extremely porous and allows all of the 
proteins (regardless of size) to quickly reach the bottom of it before entering the resolving 
gel. This is important so that all of the sample molecules start at the same height on the 
gel at the same time. The resolving gel allows for the separation of the proteins by their 
mass [1]. The analysis of representative gels was quantified using ImageJ software [11]. 
ImageJ analyzes lanes of equal size to be able quantitatively compare bands of an SDS-
PAGE gel [11]. The primary bands can be compared by creating an area histogram of the 
intensities of each SDS-PAGE lane. The areas can then be normalized and compared 
against each other to observe the rate of formation.  Representative gels from each 
quinone were analyzed using ImageJ software. 
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Chapter III 
Results and Conclusions 
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3.1 Introduction 
 
This chapter covers the results and conclusions of the experiments on the protein-
crosslinking effects of PBQ, MBQ, and CBQ on lysozyme. The experiments show the 
effects of the quinones on lysozyme over a time- and concentration-dependent manner as 
compared with a control. They are then compared against each other to gain a greater 
understanding of the possible results of a substituent effect of the groups on MBQ and 
CBQ when reacted with lysozyme. This will help elucidate how electron donating and 
electron withdrawing groups may affect their reactivity. All of the results in this chapter 
are presented in the form of SDS-PAGE gels that analyze these reactions. 
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3.2 Results  
 
3.2.1 SDS-PAGE of PBQ and Lysozyme 
Figure 3.4.1 shows the SDS-PAGE gel of the reaction of 0.10 mM lysozyme with 
3.0 mM PBQ. In the 10 (L2) and 30 (L3) min wells, dimer formation is seen at 
approximately 27 kDa with slight trimer formation at approximately 42 kDa. In the 60 
(L4), 120 (L5), and 180 (L6) min wells, oligomerization and aggregation are seen in 
addition to trimers, with the aggregation being most substantial at 120 min (L5). After 
120 min, the bands begin to fade because there is a solubility issue of the formed protein 
aggregate that was not able to reach the resolving gel. This is further confirmed by the 
solid dark brown plaques seen in the wells past 240 min (L7) for PBQ at this 
concentration. This gel was analyzed using the ImageJ software, and the results of this 
analysis are in Table 3.4.1. 
Figure 3.4.2 shows the gel for the reaction of lysozyme (0.10 mM) with PBQ (1.0 
mM). There is a substantial decrease in aggregate formation as compared to the PBQ (3.0 
mM) gel. The 10 (L2) and 30 min (L3) wells only display mild formation of lysozyme 
dimers, whereas in the PBQ (3.0 mM) run, they were already forming trimers. Noticeable 
aggregation does not occur until the 180 (L6) and 240 min (L7) wells, and it is never as 
striking as seen in the PBQ (3.0 mM) runs. The trimer formation is not as drastic as seen 
in the PBQ (3.0 mM) run either. There was a small amount of plaque in the 300 min (L8) 
well and a large amount in the 24 hr (L9) well at PBQ (1.0 mM). 
Figure 3.4.3 shows the SDS-PAGE results for the reaction of lysozyme (0.10 
mM) with PBQ (0.50 mM). This concentration of PBQ is only a five times that of the 
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protein itself. As would be expected with the trends described above, the PBQ (0.50 mM) 
run has significantly less oligomerization and aggregation. True dimer formation does not 
occur until one hr (L4) into the reaction. Polymeric aggregation is not seen until the 24 hr 
(L9) reaction. At this concentration of PBQ, there was no precipitate in any of the wells, 
including the 24 hr (L9) well. 
Figure 3.4.4 shows lysozyme reacted with PBQ (0.10 mM), which is the lowest 
experimental concentration of quinone. At this concentration, the concentration of 
quinone is equal to the concentration of lysozyme. Dimer formation still occurred fairly 
readily at the 60 min (L4) well; however, no other significant product was ascertained 
until the 24 hr (L9) well. The dimer bands slightly increased in intensity after each hr. No 
aggregation was displayed at this low of a concentration, not even in the 24 hr (L9) well. 
 
3.2.3 SDS-PAGE of CBQ and Lysozyme 
 Figure 3.4.5 shows the results of lysozyme (0.10 mM) reacted with CBQ 
(3.0 mM). During the incubation, red-brown plaque formation occurred in as early as 30 
min (L3), and the same trend was observed in the wells of the SDS-PAGE gels. Dimer 
formation occurred readily in 10 min (L2) for this concentration. At 30 min (L3), and all 
the way to 24 hr (L9), trimer formation and further aggregation was seen on the gel, 
along with red-brown plaques resting in the wells of the gel. The aggregation for CBQ is 
much more severe than that of PBQ, and the bands are much more defined. CBQ’s 
reactivity with lysozyme is most likely more intense than that of PBQ because the 
chloride group is electron withdrawing, enhancing its reactivity. This gel was analyzed 
using the ImageJ software, and the results of this analysis are in Table 3.4.2. 
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 Figure 3.4.6 shows the results of lysozyme (0.10 mM) reacted with CBQ (1.0 
mM). Dimer formation still occurs at 10 min (L2), although it is much less than that of 
the CBQ (3.0 mM) reaction. Trimer formation does resolve until the 60 min (L4) well, 
whereas aggregate bands do not appear until 120 min (L5) and onward. Visible plaques 
in the wells of the CBQ (1.0 mM) reaction were not seen until the 240 min (L7) sample 
of CBQ. This is a drastic reduction from the CBQ (3.0 mM) experiment, which had 
plaque formation as early as 30 min (L3) into the experiment, but this is to be expected 
with the drop in concentration from 30 to 1 (CBQ to lysozyme) to a 10 to 1 reaction. The 
most intense banding of the CBQ (1.0 mM) reaction is at the 3 (L6) to 5 hr (L8) range, 
with 24 hr (L9) being slightly faded in comparison. This is most likely indicative of 
extensive polymeric aggregation occurring in the time frame between 5 to 24 hr (L8 and 
L9). 
 Figure 3.4.7 shows the gel resulting from the analysis of lysozyme with CBQ 
(0.50 mM). The formation of oligomeric products has decreased drastically from the 
CBQ (1.0 mM) concentration.  Dimer formation is still present in as early as 10 min (L2), 
although it is only a very light band. Very faint trimer bands can be seen at the 180 min 
(L6) and onward wells. There are some light bands at 180 min (L6) and past, indicating a 
small amount of aggregate formation. There were no visible plaques seen in any of the 
wells of this experiment. By analyzing this gel, it appears that CBQ readily induces 
lysozyme to undergo oligomerization into dimers, but further polymerization is not as 
easily achieved.  
 Figure 3.4.8 displays the results of SDS-PAGE for the reaction between lysozyme 
(0.10 mM) and CBQ (0.10 mM). The 1 to 1 reaction of CBQ and lysozyme shows a 
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much faster formation of dimers when compared to similar concentrations of PBQ. In 
fact, dimer formation still occurs at the 10 min (L2) well, although the band is faint. A 
very faint trimer band can be seen in the 24 hr (L9) well, but the rest of the wells only 
have the formation of dimers. This further substantiates that CBQ can readily induce 
lysozyme to cross-link into a dimer, but addition of further units does not readily occur 
until much higher concentrations of CBQ are achieved. 
 
3.2.4 SDS-PAGE of MBQ and Lysozyme 
 Figure 3.4.9 shows the results of SDS-PAGE of lysozyme (0.10 mM) 
reacted with MBQ (3.0 mM). Even at the high concentration of 30 to 1 MBQ to 
lysozyme, the electron donating effect is very apparent in the lack of reactivity leading to 
protein crosslinking. Dimer formation occurs minimally at the 120 min (L5) mark, with 
no oligomerization in the wells before it. There is a slight band at approximately 42 kDa 
that may be a trimer in the 24 hr (L9) well, but there is no polymeric aggregation or 
further oligomerization induced by MBQ. The reactivity is substantially lower than both 
PBQ and CBQ, and even at this high concentration, almost no protein crosslinking 
occurs. There was no plaque formation during the incubation or SDS-PAGE experiments. 
This gel was analyzed using the ImageJ software, and the results of this analysis are in 
Table 3.4.3. 
 Figure 3.4.10 displays the SDS-PAGE results of lysozyme (0.10 mM) reacted 
with MBQ (1.0 mM). Dimer formation does not occur until the 5 hr (L8) mark, which is 
in stark contrast to CBQ which had heavy dimerization at 10 min (L2) in similar 
concentrations of lysozyme and CBQ. The SDS-PAGE experiments do not show if other 
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pathways of reactivity are taken by the MBQ, but as far as protein cross-linking, only 
minimal amounts occur for this benzoquinone. 
 Figure 3.4.11 shows the resulting gel of lysozyme (0.10 mM) incubated with 
MBQ (0.50 mM). There is a faint dimer band in the 24 hr (L9) well. Other than that, no 
other significant findings are marked. 
 Figure 3.4.12 shows the resulting gel of lysozyme (0.10 mM) reacted with MBQ 
(0.10 mM). There is a possible faint dimer band at 24 hr (L9), but the 1 to 1 reaction has 
very little reactivity with lysozyme. There are no other significant findings from this gel. 
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3.3 Conclusions 
 In conclusion, lysozyme is readily modified by the three benzoquinones of 
interest (PBQ, CBQ, and MBQ) under physiological conditions (37 °C and pH=7.0). 
These results are confirmed by SDS-PAGE experiments which show dimer, trimer, and 
polymeric aggregate formation from reactions between lysozyme and quinone when 
compared to controls with just lysozyme. Quantitative analysis of the gels by ImageJ 
software leads to the same results. Furthermore, this reaction of protein cross-linking is 
shown to be dependent on the concentration of quinone, along with a direct relationship 
between the length of the reaction and the extent of modification of lysozyme. The SDS-
PAGE experiments also display the implication of the substituent effect on lysozyme 
modification by benzoquinones. CBQ, with an electron withdrawing chloride, was by far 
the most reactive of the benzoquinones tested. CBQ readily induced formation of dimers 
and polymeric aggregates, even at lower concentrations. It also formed amyloidogenic 
plaques in as little as 30 min at a 3.0 mM concentration of CBQ. MBQ, on the other 
hand, had an electron donating methyl group which was shown to cause a substantial 
decrease in the reactivity of the benzoquinone. MBQ only formed products at high 
concentrations and longer incubation times. PBQ, with no substituent, showed an 
intermediate level of reactivity when compared to CBQ and MBQ. It readily formed 
aggregates at high concentration and long incubation times, but did not at lower 
concentrations and shorter incubation times. 
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3.4 Figures 
Figure 3.4.1. SDS-PAGE PBQ (3.0 mM) with Lysozyme (0.10 mM) (Data Duplicated)  
 
 
             
SDS-PAGE gel of reaction between PBQ (3.0 mM) with Lysozyme (0.10 mM) at 37 °C 
in a time-dependent manner at pH 7.0. The 24 hr control contained only lysozyme and 
phosphate buffer (50 mM, pH 7.0). Samples were transferred immediately to -20 °C 
freezer to halt the reaction at the specified time.  
 MM (Molecular Marker) 
 L1: 24 hr Control Lysozyme 
 L2: 10 Min Reaction with PBQ 
 L3: 30 Min Reaction with PBQ 
 L4: 60 Min Reaction with PBQ 
 L5: 120 Min Reaction with PBQ 
 L6: 180 Min Reaction with PBQ 
 L7: 240 Min Reaction with PBQ 
 L8: 300 Min Reaction with PBQ 
 L9: 24 hr Reaction with PBQ 
 
Table 3.4.1: Normalized Ratios of Band Intensities for PBQ 3.0 mM 
 
 
Control 10 min 30 min 60 min 120 min 180 min 240 min 300 min 24 hr
Initial 1 0.74997 0.61051 0.52979 0.55584 0.59859 0.65932 0.71015 0.89591
Dimer 0 0.20445 0.29983 0.32470 0.31025 0.26166 0.21432 0.22828 0.10409
Trimer 0 0.04559 0.08966 0.14550 0.13392 0.13975 0.12636 0.06157 0.00000
200kDa - 
50kDa - 
30kDa - 
15kDa - 
MM L1 L2 L3 L4 L5 L6 L7 L8 L9 
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Figure 3.4.2. SDS-PAGE PBQ (1.0 mM) with Lysozyme (0.10 mM) (Data Duplicated) 
 
 
 
SDS-PAGE gel of reaction between PBQ (1.0 mM) with Lysozyme (0.10 mM) at 37 °C 
in a time-dependent manner at pH 7.0. The 24 hr control contained only lysozyme and 
phosphate buffer (50 mM, pH 7.0). Samples were transferred immediately to -20 °C 
freezer to halt the reaction at the specified time.  
 MM (Molecular Marker) 
 L1: 24 hr Control Lysozyme 
 L2: 10 Min Reaction with PBQ 
 L3: 30 Min Reaction with PBQ 
 L4: 60 Min Reaction with PBQ 
 L5: 120 Min Reaction with PBQ 
 L6: 180 Min Reaction with PBQ 
 L7: 240 Min Reaction with PBQ 
 L8: 300 Min Reaction with PBQ 
 L9: 24 hr Reaction with PBQ 
  
  
200kDa - 
50kDa - 
30kDa - 
15kDa - 
MM L1 L2 L3 L4 L5 L6 L7 L8 L9 
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Figure 3.4.3. SDS-PAGE PBQ (0.50 mM) with Lysozyme (0.10 mM) (Data Duplicated) 
 
 
 
SDS-PAGE gel of reaction between PBQ (0.50 mM) with Lysozyme (0.10 mM) at 37 °C 
in a time-dependent manner at pH 7.0. The 24 hr control contained only lysozyme and 
phosphate buffer (50 mM, pH 7.0). Samples were transferred immediately to -20 °C 
freezer to halt the reaction at the specified time.  
 MM (Molecular Marker) 
 L1: 24 hr Control Lysozyme 
 L2: 10 Min Reaction with PBQ 
 L3: 30 Min Reaction with PBQ 
 L4: 60 Min Reaction with PBQ 
 L5: 120 Min Reaction with PBQ 
 L6: 180 Min Reaction with PBQ 
 L7: 240 Min Reaction with PBQ 
 L8: 300 Min Reaction with PBQ 
 L9: 24 hr Reaction with PBQ 
  
  
200kDa - 
50kDa - 
30kDa - 
15kDa - 
MM L1 L2 L3 L4 L5 L6 L7 L8 L9 
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Figure 3.4.4. SDS-PAGE PBQ (0.10 mM) with Lysozyme (0.10 mM) (Data Duplicated) 
 
 
 
SDS-PAGE gel of reaction between PBQ (0.10 mM) with Lysozyme (0.10 mM) at 37 °C 
in a time-dependent manner at pH 7.0. The 24 hr control contained only lysozyme and 
phosphate buffer (50 mM, pH 7.0). Samples were transferred immediately to -20 °C 
freezer to halt the reaction at the specified time.  
 MM (Molecular Marker) 
 L1: 24 hr Control Lysozyme 
 L2: 10 Min Reaction with PBQ 
 L3: 30 Min Reaction with PBQ 
 L4: 60 Min Reaction with PBQ 
 L5: 120 Min Reaction with PBQ 
 L6: 180 Min Reaction with PBQ 
 L7: 240 Min Reaction with PBQ 
 L8: 300 Min Reaction with PBQ 
 L9: 24 hr Reaction with PBQ 
  
  
200kDa - 
50kDa - 
30kDa - 
15kDa - 
MM L1 L2 L3 L4 L5 L6 L7 L8 L9 
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Figure 3.4.5. SDS-PAGE CBQ (3.0 mM) with Lysozyme (0.10 mM) (Data Duplicated) 
 
 
 
SDS-PAGE gel of reaction between CBQ (3.0 mM) with Lysozyme (0.10 mM) at 37 °C 
in a time-dependent manner at pH 7.0. The 24 hr control contained only lysozyme and 
phosphate buffer (50 mM, pH 7.0). Samples were transferred immediately to -20 °C 
freezer to halt the reaction at the specified time.  
 MM (Molecular Marker) 
 L1: 24 hr Control Lysozyme 
 L2: 10 Min Reaction with CBQ 
 L3: 30 Min Reaction with CBQ 
 L4: 60 Min Reaction with CBQ 
 L5: 120 Min Reaction with CBQ 
 L6: 180 Min Reaction with CBQ 
 L7: 240 Min Reaction with CBQ 
 L8: 300 Min Reaction with CBQ 
 L9: 24 hr Reaction with CBQ 
 
Table 3.4.2: Normalized Ratios of Band Intensities for CBQ 3.0 mM 
 
 
Control 10 min 30 min 60 min 120 min 180 min 240 min 300 min 24 hr
Initial 1 0.73480 0.67876 0.59273 0.58289 0.57302 0.59153 0.58705 0.76589
Dimer 0 0.20559 0.24332 0.30044 0.33213 0.29858 0.30677 0.27210 0.15595
Trimer 0 0.05961 0.07792 0.10683 0.08497 0.12840 0.10169 0.14085 0.07816
200kDa - 
50kDa - 
30kDa - 
15kDa - 
MM L1 L2 L3 L4 L5 L6 L7 L8 L9 
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Figure 3.4.6. SDS-PAGE CBQ (1.0 mM) with Lysozyme (0.10 mM) (Data Duplicated) 
 
 
 
SDS-PAGE gel of reaction between CBQ (1.0 mM) with Lysozyme (0.10 mM) at 37 °C 
in a time-dependent manner at pH 7.0. The 24 hr control contained only lysozyme and 
phosphate buffer (50 mM, pH 7.0). Samples were transferred immediately to -20 °C 
freezer to halt the reaction at the specified time.  
 MM (Molecular Marker) 
 L1: 24 hr Control Lysozyme 
 L2: 10 Min Reaction with CBQ 
 L3: 30 Min Reaction with CBQ 
 L4: 60 Min Reaction with CBQ 
 L5: 120 Min Reaction with CBQ 
 L6: 180 Min Reaction with CBQ 
 L7: 240 Min Reaction with CBQ 
 L8: 300 Min Reaction with CBQ 
 L9: 24 hr Reaction with CBQ 
  
  
200kDa - 
50kDa - 
30kDa - 
15kDa - 
MM L1 L2 L3 L4 L5 L6 L7 L8 L9 
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Figure 3.4.7. SDS-PAGE CBQ (0.50 mM) with Lysozyme (0.10 mM) (Data Duplicated) 
 
 
 
SDS-PAGE gel of reaction between CBQ (0.50 mM) with Lysozyme (0.10 mM) at 37 °C 
in a time-dependent manner at pH 7.0. The 24 hr control contained only lysozyme and 
phosphate buffer (50 mM, pH 7.0). Samples were transferred immediately to -20 °C 
freezer to halt the reaction at the specified time.  
 MM (Molecular Marker) 
 L1: 24 hr Control Lysozyme 
 L2: 10 Min Reaction with CBQ 
 L3: 30 Min Reaction with CBQ 
 L4: 60 Min Reaction with CBQ 
 L5: 120 Min Reaction with CBQ 
 L6: 180 Min Reaction with CBQ 
 L7: 240 Min Reaction with CBQ 
 L8: 300 Min Reaction with CBQ 
 L9: 24 hr Reaction with CBQ 
  
  
200kDa - 
50kDa - 
30kDa - 
15kDa - 
MM L1 L2 L3 L4 L5 L6 L7 L8 L9 
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Figure 3.4.8. SDS-PAGE CBQ (0.10 mM) with Lysozyme (0.10 mM) (Data Duplicated) 
 
 
 
SDS-PAGE gel of reaction between CBQ (0.10 mM) with Lysozyme (0.10 mM) at 37 °C 
in a time-dependent manner at pH 7.0. The 24 hr control contained only lysozyme and 
phosphate buffer (50 mM, pH 7.0). Samples were transferred immediately to -20 °C 
freezer to halt the reaction at the specified time.  
 MM (Molecular Marker) 
 L1: 24 hr Control Lysozyme 
 L2: 10 Min Reaction with CBQ 
 L3: 30 Min Reaction with CBQ 
 L4: 60 Min Reaction with CBQ 
 L5: 120 Min Reaction with CBQ 
 L6: 180 Min Reaction with CBQ 
 L7: 240 Min Reaction with CBQ 
 L8: 300 Min Reaction with CBQ 
 L9: 24 hr Reaction with CBQ 
  
  
200kDa - 
50kDa - 
30kDa - 
15kDa - 
MM L1 L2 L3 L4 L5 L6 L7 L8 L9 
49 
 
Figure 3.4.9. SDS-PAGE MBQ (3.0 mM) with Lysozyme (0.10 mM) (Data Duplicated) 
 
 
 
SDS-PAGE gel of reaction between MBQ (3.0 mM) with Lysozyme (0.10 mM) at 37 °C 
in a time-dependent manner at pH 7.0. The 24 hr control contained only lysozyme and 
phosphate buffer (50 mM, pH 7.0). Samples were transferred immediately to -20 °C 
freezer to halt the reaction at the specified time.  
 MM (Molecular Marker) 
 L1: 24 hr Control Lysozyme 
 L2: 10 Min Reaction with MBQ 
 L3: 30 Min Reaction with MBQ 
 L4: 60 Min Reaction with MBQ 
 L5: 120 Min Reaction with MBQ 
 L6: 180 Min Reaction with MBQ 
 L7: 240 Min Reaction with MBQ 
 L8: 300 Min Reaction with MBQ 
 L9: 24 hr Reaction with MBQ 
  
Table 3.4.3: Normalized Ratios of Band Intensities for MBQ 3.0 mM 
 
Control 10 min 30 min 60 min 120 min 180 min 240 min 300 min 24 hr
Initial 1.00000 0.90926 0.80546 0.88535 0.70443 0.73124 0.67725 0.75168 0.44026
Dimer 0.00000 0.09074 0.19454 0.11465 0.29557 0.26876 0.32275 0.24832 0.47248
Trimer 0.00000 0.00000 0.00000 0.00000 0.00000 0.00000 0.00000 0.00000 0.08726
200kDa - 
50kDa - 
30kDa - 
15kDa - 
MM L1 L2 L3 L4 L5 L6 L7 L8 L9 
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Figure 3.4.10. SDS-PAGE MBQ (1.0 mM) with Lysozyme (0.10 mM) (Data Duplicated) 
 
 
 
SDS-PAGE gel of reaction between MBQ (1.0 mM) with Lysozyme (0.10 mM) at 37 °C 
in a time-dependent manner at pH 7.0. The 24 hr control contained only lysozyme and 
phosphate buffer (50 mM, pH 7.0). Samples were transferred immediately to -20 °C 
freezer to halt the reaction at the specified time.  
 MM (Molecular Marker) 
 L1: 24 hr Control Lysozyme 
 L2: 10 Min Reaction with MBQ 
 L3: 30 Min Reaction with MBQ 
 L4: 60 Min Reaction with MBQ 
 L5: 120 Min Reaction with MBQ 
 L6: 180 Min Reaction with MBQ 
 L7: 240 Min Reaction with MBQ 
 L8: 300 Min Reaction with MBQ 
 L9: 24 hr Reaction with MBQ 
  
  
200kDa - 
50kDa - 
30kDa - 
15kDa - 
MM L1 L2 L3 L4 L5 L6 L7 L8 L9 
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Figure 3.4.11. SDS-PAGE MBQ (0.50 mM) with Lysozyme (0.10 mM) (Data 
Duplicated) 
 
 
 
 
SDS-PAGE gel of reaction between MBQ (0.50 mM) with Lysozyme (0.10 mM) at 37 
°C in a time-dependent manner at pH 7.0. The 24 hr control contained only lysozyme and 
phosphate buffer (50 mM, pH 7.0). Samples were transferred immediately to -20 °C 
freezer to halt the reaction at the specified time.  
 MM (Molecular Marker) 
 L1: 24 hr Control Lysozyme 
 L2: 10 Min Reaction with MBQ 
 L3: 30 Min Reaction with MBQ 
 L4: 60 Min Reaction with MBQ 
 L5: 120 Min Reaction with MBQ 
 L6: 180 Min Reaction with MBQ 
 L7: 240 Min Reaction with MBQ 
 L8: 300 Min Reaction with MBQ 
 L9: 24 hr Reaction with MBQ 
  
  
200kDa - 
50kDa - 
30kDa - 
15kDa - 
MM L1 L2 L3 L4 L5 L6 L7 L8 L9 
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Figure 3.4.12. SDS-PAGE MBQ (0.10 mM) with Lysozyme (0.10 mM) (Data 
Duplicated) 
 
 
 
SDS-PAGE gel of reaction between MBQ (0.10 mM) with Lysozyme (0.10 mM) at 37 
°C in a time-dependent manner at pH 7.0. The 24 hr control contained only lysozyme and 
phosphate buffer (50 mM, pH 7.0). Samples were transferred immediately to -20 °C 
freezer to halt the reaction at the specified time. 
 MM (Molecular Marker) 
 L1: 24 hr Control Lysozyme 
 L2: 10 Min Reaction with MBQ 
 L3: 30 Min Reaction with MBQ 
 L4: 60 Min Reaction with MBQ 
 L5: 120 Min Reaction with MBQ 
 L6: 180 Min Reaction with MBQ 
 L7: 240 Min Reaction with MBQ 
 L8: 300 Min Reaction with MBQ 
 L9: 24 hr Reaction with MBQ 
  
 
200kDa - 
50kDa - 
30kDa - 
15kDa - 
MM L1 L2 L3 L4 L5 L6 L7 L8 L9 
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Appendix A 
Optimization of SDS-PAGE Experiments 
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SDS-PAGE experiments are a long and arduous process that cannot be mastered 
the first time. Appendix A covers initial gels that were the results of optimization 
experiments to obtain the best parameters and to refine experimental technique. Some of 
the parameters that were experimented with were the times that the gels ran, the 
concentration of electrode buffer, the loading volumes, and the dyes used to stain the 
gels. Figure A.1 shows the first SDS-PAGE experiment with lysozyme and PBQ at 
concentrations of 0.145 and 5.0 mM, respectively. The intent of this experiment was to 
optimize the conditions to detect protein modifications utilizing SDS-PAGE. If the 
concentration of lysozyme is too high or too low, the data will not be useful or be able to 
resolve the effective oligomerization that was under scrutiny. Similar results would be 
seen with excessive amounts of quinone reactant. Lysozyme controls were ran for both 0 
and 24 hr, to observe any change that occurred to lysozyme on its own while in vitro.  
The 10 min (L3) well shows heavy dimer formation and slight trimer formation. 
The wells of 30 min (L4) and 60 min (L5) show dimer, trimer, and polymeric aggregate 
formation. The aggregate formation is seen in the striking bands in the higher kDa ranges. 
The oligomer bands have almost completely faded for 180 min (L6) and 24 hr (L7) 
reaction wells due to the heavy aggregation, leading to polymers of lysozyme with high 
molecular mass. The lysozyme aggregates formed at 180 min (L6) and 24 hr (L7) are so 
massive, they do not even reach the 200 kDa cut off range. This indicates that with the 
current conditions, the reaction is proceeding too fast to observe an even time gradient. 
Figures 3.4.2 and 3.4.3 show SDS-PAGE of lysozyme (0.145mM) after treatment of PBQ 
(1.5 mM). Both of these gels have defects (the 60 min well was skipped for Figure 3.4.2 
and physical damage was sustained by the gel in Figure 3.4.3), however, and a stark jump 
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between the first and second hr is still seen.  Figure 3.4.4 shows lysozyme at a very low 
concentration of 0.050 mM reacted with PBQ (1.5 mM), but only for a total of 5 hr. The 
bands on this gel are faint, so an increase in lysozyme concentration is desired. 
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Figure A.1. SDS-PAGE PBQ (5.0 mM) with Lysozyme (0.145 mM) 
 
 
 
SDS-PAGE gel of reaction between PBQ (5.0 mM) with Lysozyme (0.145 mM) at 37 °C 
in a time-dependent manner at pH 7.0. The 0 and 24 hr controls contained only lysozyme 
and phosphate buffer (50 mM, pH 7.0). Samples were transferred immediately to -20 °C 
freezer to halt the reaction at the specified time. 
MM (Molecular Marker) 
 L1: 0 hr Control Lysozyme  
 L2: 24 hr  Control Lysozyme 
 L3: 10 Min Reaction with PBQ 
 L4: 30 Min Reaction with PBQ 
 L5: 60 Min Reaction with PBQ 
 L6: 180 Min Reaction with PBQ 
 L7: 24 hr Reaction with PBQ 
  
  
200kDa - 
50kDa - 
30kDa - 
15kDa - 
MM L1 L2 L3 L4 L5 L6 L7 
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Figure A.2. SDS-PAGE PBQ (1.5 mM) with Lysozyme (0.145 mM) (Data Duplicated) 
 
 
 
SDS-PAGE gel of reaction between PBQ (1.5 mM) with Lysozyme (0.145 mM) at 37 °C 
in a time-dependent manner at pH 7.0. The 0 and 24 hr controls contained only lysozyme 
and phosphate buffer (50 mM, pH 7.0). Samples were transferred immediately to -20 °C 
freezer to halt the reaction at the specified time. L5 was not loaded. 
 MM (Molecular Marker) 
 L1: 0 hr Control Lysozyme 
 L2: 24 hr Control Lysozyme 
 L3: 10 Min Reaction with PBQ 
 L4: 30 Min Reaction with PBQ 
 L5: 60 Min Reaction with PBQ 
 L6: 120 Min Reaction with PBQ 
 L7: 180 Min Reaction with PBQ 
 L8: 240 Min Reaction with PBQ 
 L9: 24 hr Reaction with PBQ 
  
  
200kDa - 
50kDa - 
30kDa - 
15kDa - 
MM L1 L2 L3 L4 L5 L6 L7 L8 L9 
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Figure A.3. SDS-PAGE PBQ (1.5 mM) with Lysozyme (0.145 mM) (Data Duplicated) 
 
 
 
SDS-PAGE gel of reaction between PBQ (1.5 mM) with Lysozyme (0.145 mM) at 37 °C 
in a time-dependent manner at pH 7.0. The 0 and 24 hr controls contained only lysozyme 
and phosphate buffer (50 mM, pH 7.0). Samples were transferred immediately to -20 °C 
freezer to halt the reaction at the specified time. Note defect over L8/L9. 
 MM (Molecular Marker) 
 L1: 0 hr Control Lysozyme 
 L2: 24 hr Control Lysozyme 
 L3: 10 Min Reaction with PBQ 
 L4: 30 Min Reaction with PBQ 
 L5: 60 Min Reaction with PBQ 
 L6: 120 Min Reaction with PBQ 
 L7: 180 Min Reaction with PBQ 
 L8: 240 Min Reaction with PBQ 
 L9: 24 hr Reaction with PBQ 
  
  
  
200kDa - 
50kDa - 
30kDa - 
15kDa - 
MM L1 L2 L3 L4 L5 L6 L7 L8 L9 
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Figure A.4. SDS-PAGE PBQ (1.5 mM) with Lysozyme (0.050 mM)  
 
 
 
SDS-PAGE gel of reaction between PBQ (1.5 mM) with Lysozyme (0.050 mM) at 37 °C 
in a time-dependent manner at pH 7.0. The 0 and 5 hr controls contained only lysozyme 
and phosphate buffer (50 mM, pH 7.0). Samples were transferred immediately to -20 °C 
freezer to halt the reaction at the specified time.  
 MM (Molecular Marker) 
 L1: 0 hr Control Lysozyme 
 L2: 5 hr Control Lysozyme 
 L3: 10 Min Reaction with PBQ 
 L4: 30 Min Reaction with PBQ 
 L5: 60 Min Reaction with PBQ 
 L6: 120 Min Reaction with PBQ 
 L7: 180 Min Reaction with PBQ 
 L8: 240 Min Reaction with PBQ 
 L9: 300 Min Reaction with PBQ 
  
200kDa - 
50kDa - 
30kDa - 
15kDa - 
MM L1 L2 L3 L4 L5 L6 L7 L8 L9 
60 
 
Appendix B 
Incubation Tables 
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 The tables provided in this appendix give the experimental details of each 
experiment. They contain information such as the volumes of solutions used, times, and 
loading volumes. These tables serve as an effective guide book of each experiment. They 
display the time- and concentration-dependent manner of the experiments, as well as give 
the details of the SDS-PAGE experiment.
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0514 2013, [Q] 5.0 mM FW mmol mg solution [Q]i [Q]f Incub Vol Q vol
20 mM/50ml stock, PBQ 108.10 1.00 108.10 20 5 180 45
Actual PBQ
(uL)Final Lys->0.145 mM 
mg ml
Lys vol 37.4
Stock Lys 0.698 20 2
Freezing time
Total MM  Ctr 0 Ctr 24h 10 30 1h 3h 24h
0.698 mM St Lys (uL) 37.4 6.2 6.2
Protein (ug) 375.5 62.6 62.6 62.6 62.6 62.6 62.6 62.6
Phosphate buffer (uL) 97.6 23.8 23.8
Incub Time 0 min 5hr 10 min 30 min 1h 3h 24h
Incub Temp 37oC
20 mM Q stock, [Q]f 0.5 mM 45 0.0 0.0
Final Incubate Vol (uL) 180 30 30
Aliquot Taken (uL) X 4 30 30 30 30 30 Tot FIN vol
3 x 10 3 x 10 3 x 10  3 x 10 3 x 10 3 x 10 3 x 10 150.0
LANE L1 L2 L3 L4 L5 L6 L8 L10
MM Ctr 0 Ctr 24h 10 30 1h 3h 24h
Loading Dye 0 10 10 10 10 10 10 10
Incub Aliquot of Total 0 10 10 10 10 10 10 10
Loading Vol (uL) 12 10 10 10 10 10 10 10
Protein loaded (ug) 7 10 10 10 10 10 10
0.15 mM Lys(ug),25ul 32
0.10 mM Lys(ug),25ul 22
0.05 mM Lys(ug),25ul 11
in 10%MeOH/buffer
Table B.1. Reaction details of PBQ (5.0 mM) with Lysozyme (0.145 mM) 
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0521 2013, [Q] 1.5 mM FW mmol mg solution [Q]i [Q]f Incub Vol Q vol
5 mM/50ml stock, PBQ 108.10 0.25 27.03 5 1.5 252 75.6
Actual PBQ
(uL)Final Lys->0.145 mM 
mg ml
Lys vol 52.3
Stock Lys 0.698 20 2
Freezing time
Total MM  Ctr 0 Ctr 24h 10 30 1h 2h 3h 4h 24h
0.698 mM St Lys (uL) 52.3 6.2 6.2
Protein (ug) 525.7 62.6 62.6 62.6 62.6 62.6 62.6 62.6 62.6 62.6
Phosphate buffer (uL) 124.1 23.8 23.8
Incub Time 0 min 5hr 10 min 30 min 1h 2h 3h 4h 24h
Incub Temp 37oC
20 mM Q stock, [Q]f 0.5 mM 75.6 0.0 0.0
Final Incubate Vol (uL) 252 30 30
Aliquot Taken (uL) X 4 30 30 30 30 30 30 30 Tot FIN vol
3 x 10 3 x 10 3 x 10  3 x 10 3 x 10 3 x 10 3 x 10 3 x 10 3 x 10 210.0
LANE L1 L2 L3 L4 L5 L6 L7 L8 L10
MM Ctr 0 Ctr 24h 10 30 1h 2h 3h 4h 24h
Loading Dye 0 10 10 10 10 10 10 10 10 10
Incub Aliquot of Total 0 10 10 10 10 10 10 10 10 10
Loading Vol (uL) 12 10 10 10 10 10 10 10 10 10
Protein loaded (ug) 10 10 10 10 10 10 10 10 10
0.15 mM Lys(ug),25ul 32
0.10 mM Lys(ug),25ul 22
0.05 mM Lys(ug),25ul 11
in 10%MeOH/buffer
Table B.2. Reaction details of PBQ (1.5 mM) with Lysozyme (0.145 mM) 
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0522 2013, [Q] 1.5 mM FW mmol mg solution [Q]i [Q]f Incub Vol Q vol
20 mM/50ml stock, PBQ 108.10 1.00 108.10 20 1.5 540 40.5
Actual PBQ
(uL)Final Lys->0.05 mM mg ml Lys vol 38.7
Stock Lys 0.698 20 2
Freezing time
Total MM  Ctr 0 Ctr 5h 10 30 1h 2h 3h 4h 5h 24h
0.698 mM St Lys (uL) 38.7 4.3 4.3
Protein (ug) 388.5 43.2 43.2 32.4 32.4 32.4 32.4 32.4 32.4 32.4 32.4
Phosphate buffer (uL) 460.8 55.7 55.7
Incub Time 0 min 5hr 10 min 30 min 1h 2h 3h 4h 5h 24h
Incub Temp 37oC
20 mM Q stock, [Q]f 0.5 mM 40.5 0.0 0.0
Final Incubate Vol (uL) 540 60 60
Aliquot Taken (uL) X 4 45 45 45 45 45 45 45 45 Tot FIN vol
3 x 15 3 x 15 3 x 15  3 x 15 3 x 15  3 x 15  3 x 15 3 x 15 3 x 15 3 x 15 270.0
LANE L1 L2 L3 L4 L5 L6 L7 L8 L9 L10
MM Ctr 0 Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
Loading Dye 0 10 10 10 10 10 10 10 10 10 10
Incub Aliquot of Total 0 15 15 15 15 15 15 15 15 15 15
Loading Vol (uL) 12 16 16 16 16 16 16 16 16 16 16
Protein loaded (ug) 7 7 7 7 7 7 7 7 7 7
0.15 mM Lys(ug),25ul 32
0.10 mM Lys(ug),25ul 22
0.05 mM Lys(ug),25ul 11
in 10%MeOH/buffer
Table B.3. Reaction details of PBQ (1.5 mM) with Lysozyme (0.050 mM) 
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0603 2013, [Q] 3.0 mM FW mmol mg solution [Q]i [Q]f Incub Vol Q vol
20 mM/50ml stock, PBQ 108.10 1.00 108.10 20 3 540 81
Actual PBQ
(uL)Final Lys->0.1 mM mg ml Lys vol 77.3
Stock Lys 0.698 20 2
Freezing time
Total MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
0.698 mM St Lys (uL) 77.3 14.3
Protein (ug) 777.0 143.9 64.7 64.7 64.7 64.7 64.7 64.7 64.7 64.7
Phosphate buffer (uL) 381.7 85.7
Incub Time 0 min 10 min 30 min 1h 2h 3h 4h 5h 24h
Incub Temp 37oC
20 mM Q stock, [Q]f 0.5 mM 81 0.0
Final Incubate Vol (uL) 540 100
Aliquot Taken (uL) X 4 45 45 45 45 45 45 45 45 Tot FIN vol
3 x 15 3 x 15 3 x 15 3 x 15 3 x 15 3 x 15 3 x 15 3 x 15 3 x 15 270.0
LANE L1 L2 L3 L4 L5 L6 L7 L8 L9 L10
MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
Loading Dye 0 10 10 10 10 10 10 10 10 10
Incub Aliquot of Total 0 15 15 15 15 15 15 15 15 15
Loading Vol (uL) 15 23 10 10 10 10 10 10 10 10
Protein loaded (ug) 20 9 9 9 9 9 9 9 9
0.15 mM Lys(ug),25ul 32
0.10 mM Lys(ug),25ul 22
0.05 mM Lys(ug),25ul 11
in 10%MeOH/buffer
Table B.4. Reaction details of PBQ (3.0 mM) with Lysozyme (0.10 mM) 
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0603 2013, [Q] 1.0 mM FW mmol mg solution [Q]i [Q]f Incub Vol Q vol
20 mM/50ml stock, PBQ 108.10 1.00 108.10 20 1 540 27
Actual PBQ
(uL)Final Lys->0.1 mM mg ml Lys vol 77.3
Stock Lys 0.698 20 2
Freezing time
Total MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
0.698 mM St Lys (uL) 77.3 14.3
Protein (ug) 777.0 143.9 64.7 64.7 64.7 64.7 64.7 64.7 64.7 64.7
Phosphate buffer (uL) 435.7 85.7
Incub Time 0 min 10 min 30 min 1h 2h 3h 4h 5h 24h
Incub Temp 37oC
20 mM Q stock, [Q]f 0.5 mM 27 0.0
Final Incubate Vol (uL) 540 100
Aliquot Taken (uL) X 4 45 45 45 45 45 45 45 45 Tot FIN vol
3 x 15 3 x 15 3 x 15 3 x 15 3 x 15 3 x 15 3 x 15 3 x 15 3 x 15 270.0
LANE L1 L2 L3 L4 L5 L6 L7 L8 L9 L10
MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
Loading Dye 0 10 10 10 10 10 10 10 10 10
Incub Aliquot of Total 0 15 15 15 15 15 15 15 15 15
Loading Vol (uL) 15 10 10 10 10 10 10 10 10 10
Protein loaded (ug) 9 9 9 9 9 9 9 9 9
0.15 mM Lys(ug),25ul 32
0.10 mM Lys(ug),25ul 22
0.05 mM Lys(ug),25ul 11
in 10%MeOH/buffer
Table B.5. Reaction details of PBQ (1.0 mM) with Lysozyme (0.10 mM) 
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0606 2013, [Q] 0.5 mM FW mmol mg solution [Q]i [Q]f Incub Vol Q vol
5 mM/50ml stock, PBQ 108.10 0.25 27.03 5 0.5 720 72
Actual PBQ
(uL)Final Lys->0.1 mM mg ml Lys vol 103.1
Stock Lys 0.698 20 2
Freezing time
Total MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
0.698 mM St Lys (uL) 103.1 14.3
Protein (ug) 1035.9 143.9 86.3 86.3 86.3 86.3 86.3 86.3 86.3 86.3
Phosphate buffer (uL) 544.9 85.7
Incub Time 0 min 10 min 30 min 1h 2h 3h 4h 5h 24h
Incub Temp 37oC
20 mM Q stock, [Q]f 0.5 mM 72 0.0
Final Incubate Vol (uL) 720 100
Aliquot Taken (uL) X 4 60 60 60 60 60 60 60 60 Tot FIN vol
4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 360.0
LANE L1 L2 L3 L4 L5 L6 L7 L8 L9 L10
MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
Loading Dye 0 10 10 10 10 10 10 10 10 10
Incub Aliquot of Total 0 15 15 15 15 15 15 15 15 15
Loading Vol (uL) 15 10 10 10 10 10 10 10 10 10
Protein loaded (ug) 9 9 9 9 9 9 9 9 9
0.15 mM Lys(ug),25ul 32
0.10 mM Lys(ug),25ul 22
0.05 mM Lys(ug),25ul 11
in 10%MeOH/buffer
Table B.6. Reaction details of PBQ (0.50 mM) with Lysozyme (0.10 mM) 
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0606 2013, [Q] 0.1 mM FW mmol mg solution [Q]i [Q]f Incub Vol Q vol
5 mM/50ml stock, PBQ 108.10 0.25 27.03 5 0.1 720 14.4
Actual PBQ
(uL)Final Lys->0.1 mM mg ml Lys vol 103.1
Stock Lys 0.698 20 2
Freezing time
Total MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
0.698 mM St Lys (uL) 103.1 14.3
Protein (ug) 1035.9 143.9 86.3 86.3 86.3 86.3 86.3 86.3 86.3 86.3
Phosphate buffer (uL) 602.5 85.7
Incub Time 0 min 10 min 30 min 1h 2h 3h 4h 5h 24h
Incub Temp 37oC
20 mM Q stock, [Q]f 0.5 mM 14.4 0.0
Final Incubate Vol (uL) 720 100
Aliquot Taken (uL) X 4 60 60 60 60 60 60 60 60 Tot FIN vol
4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 360.0
LANE L1 L2 L3 L4 L5 L6 L7 L8 L9 L10
MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
Loading Dye 0 10 10 10 10 10 10 10 10 10
Incub Aliquot of Total 0 15 15 15 15 15 15 15 15 15
Loading Vol (uL) 15 10 10 10 10 10 10 10 10 10
Protein loaded (ug) 9 9 9 9 9 9 9 9 9
0.15 mM Lys(ug),25ul 32
0.10 mM Lys(ug),25ul 22
0.05 mM Lys(ug),25ul 11
in 10%MeOH/buffer
Table B.7. Reaction details of PBQ (0.10 mM) with Lysozyme (0.10 mM) 
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0612 2013 FW mmol mg solution [Q]i [Q]f Incub Vol Q vol
20 mM/50ml stock, CBQ 142.52 1.00 142.52 20 3 720 108
Actual CBQ
(uL)Final Lys->0.1 mM mg ml Lys vol 103.1
Stock Lys 0.698 20 2
Freezing time
Total Ctr 24h MM 10 30 1h 2h 3h 4h 5h 24h
0.698 mM St Lys (uL) 103.1 8.6
Protein (ug) 1035.9 86.3 86.3 86.3 86.3 86.3 86.3 86.3 86.3 86.3
Phosphate buffer (uL) 508.9 51.4
Incub Time 0 min 10 min 30 min 1h 2h 3h 4h 5h 24h
Incub Temp 37oC
20 mM Q stock, [Q]f 3 mM 108 0.0
Final Incubate Vol (uL) 720 60
Aliquot Taken (uL) 60 60 60 60 60 60 60 60 Tot FIN vol
3 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 360.0
LANE L1 L2 L3 L4 L5 L6 L7 L8 L9 L10
MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
Loading Dye 0 10 10 10 10 10 10 10 10 10
Incub Aliquot of Total 0 15 15 15 15 15 15 15 15 15
Loading Vol (uL) 15 10 10 10 10 10 10 10 10 10
Protein loaded (ug) 9 9 9 9 9 9 9 9 9
in 10%MeOH/buffer
Table B.8. Reaction details of CBQ (3.0 mM) with Lysozyme (0.10 mM) 
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0612 2013 FW mmol mg solution [Q]i [Q]f Incub Vol Q vol
20 mM/50ml stock, CBQ 142.52 1.00 142.52 20 1 720 36
Actual CBQ
(uL)Final Lys->0.1 mM mg ml Lys vol 103.1
Stock Lys 0.698 20 2
Freezing time
Total Ctr 24h MM 10 30 1h 2h 3h 4h 5h 24h
0.698 mM St Lys (uL) 103.1 8.6
Protein (ug) 1035.9 86.3 86.3 86.3 86.3 86.3 86.3 86.3 86.3 86.3
Phosphate buffer (uL) 580.9 51.4
Incub Time 0 min 10 min 30 min 1h 2h 3h 4h 5h 24h
Incub Temp 37oC
20 mM Q stock, [Q]f 3 mM 36 0.0
Final Incubate Vol (uL) 720 60
Aliquot Taken (uL) 60 60 60 60 60 60 60 60 Tot FIN vol
3 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 360.0
LANE L1 L2 L3 L4 L5 L6 L7 L8 L9 L10
MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
Loading Dye 0 10 10 10 10 10 10 10 10 10
Incub Aliquot of Total 0 15 15 15 15 15 15 15 15 15
Loading Vol (uL) 15 10 10 10 10 10 10 10 10 10
Protein loaded (ug) 9 9 9 9 9 9 9 9 9
in 10%MeOH/buffer
Table B.9. Reaction details of CBQ (1.0 mM) with Lysozyme (0.10 mM) 
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0612 2013 FW mmol mg solution [Q]i [Q]f Incub Vol Q vol
20 mM/50ml stock, CBQ 142.52 0.25 35.63 5 0.5 720 72
Actual CBQ
(uL)Final Lys->0.1 mM mg ml Lys vol 103.1
Stock Lys 0.698 20 2
Freezing time
Total Ctr 24h MM 10 30 1h 2h 3h 4h 5h 24h
0.698 mM St Lys (uL) 103.1 8.6
Protein (ug) 1035.9 86.3 86.3 86.3 86.3 86.3 86.3 86.3 86.3 86.3
Phosphate buffer (uL) 544.9 51.4
Incub Time 0 min 10 min 30 min 1h 2h 3h 4h 5h 24h
Incub Temp 37oC
20 mM Q stock, [Q]f 3 mM 72 0.0
Final Incubate Vol (uL) 720 60
Aliquot Taken (uL) 60 60 60 60 60 60 60 60 Tot FIN vol
3 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 360.0
LANE L1 L2 L3 L4 L5 L6 L7 L8 L9 L10
MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
Loading Dye 0 10 10 10 10 10 10 10 10 10
Incub Aliquot of Total 0 15 15 15 15 15 15 15 15 15
Loading Vol (uL) 15 10 10 10 10 10 10 10 10 10
Protein loaded (ug) 9 9 9 9 9 9 9 9 9
in 10%MeOH/buffer
Table B.10. Reaction details of CBQ (0.50 mM) with Lysozyme (0.10 mM) 
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0612 2013 FW mmol mg solution [Q]i [Q]f Incub Vol Q vol
20 mM/50ml stock, CBQ 142.52 0.25 35.63 5 0.1 720 14.4
Actual CBQ
(uL)Final Lys->0.1 mM mg ml Lys vol 103.1
Stock Lys 0.698 20 2
Freezing time
Total Ctr 24h MM 10 30 1h 2h 3h 4h 5h 24h
0.698 mM St Lys (uL) 103.1 8.6
Protein (ug) 1035.9 86.3 86.3 86.3 86.3 86.3 86.3 86.3 86.3 86.3
Phosphate buffer (uL) 602.5 51.4
Incub Time 0 min 10 min 30 min 1h 2h 3h 4h 5h 24h
Incub Temp 37oC
20 mM Q stock, [Q]f 3 mM 14.4 0.0
Final Incubate Vol (uL) 720 60
Aliquot Taken (uL) 60 60 60 60 60 60 60 60 Tot FIN vol
3 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 360.0
LANE L1 L2 L3 L4 L5 L6 L7 L8 L9 L10
MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
Loading Dye 0 10 10 10 10 10 10 10 10 10
Incub Aliquot of Total 0 15 15 15 15 15 15 15 15 15
Loading Vol (uL) 15 10 10 10 10 10 10 10 10 10
Protein loaded (ug) 9 9 9 9 9 9 9 9 9
in 10%MeOH/buffer
Table B.11. Reaction details of CBQ (0.10 mM) with Lysozyme (0.10 mM) 
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0619 2013 FW mmol mg solution [Q]i [Q]f Incub Vol Q vol
20 mM/50ml stock, MBQ 122.12 1.00 122.12 20 3 720 108
Actual MBQ
(uL)Final Lys->0.1 mM mg ml Lys vol 102.1
Stock Lys 0.705 20 2
Freezing time
Total MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
0.705 mM St Lys (uL) 102.1 14.2
Protein (ug) 1035.9 143.9 86.3 86.3 86.3 86.3 86.3 86.3 86.3 86.3
Phosphate buffer (uL) 509.9 85.8
Incub Time 0 min 10 min 30 min 1h 2h 3h 4h 5h 24h
Incub Temp 37oC
20 mM Q stock, [Q]f 3 mM 108 0.0
Final Incubate Vol (uL) 720 100
Aliquot Taken (uL) 60 60 60 60 60 60 60 60 Tot FIN vol
4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 360.0
LANE L1 L2 L3 L4 L5 L6 L7 L8 L9 L10
MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
Loading Dye 0 10 10 10 10 10 10 10 10 10
Incub Aliquot of Total 0 15 15 15 15 15 15 15 15 15
Loading Vol (uL) 15 10 10 10 10 10 10 10 10 10
Protein loaded (ug) 9 9 9 9 9 9 9 9 9
in 10%MeOH/buffer
Table B.12. Reaction details of MBQ (3.0 mM) with Lysozyme (0.10 mM) 
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0619 2013 FW mmol mg solution [Q]i [Q]f Incub Vol Q vol
20 mM/50ml stock, MBQ 122.12 1.00 122.12 20 1 720 36
Actual MBQ
(uL)Final Lys->0.1 mM mg ml Lys vol 102.1
Stock Lys 0.705 20 2
Freezing time
Total MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
0.705 mM St Lys (uL) 102.1 14.2
Protein (ug) 1035.9 143.9 86.3 86.3 86.3 86.3 86.3 86.3 86.3 86.3
Phosphate buffer (uL) 581.9 85.8
Incub Time 0 min 10 min 30 min 1h 2h 3h 4h 5h 24h
Incub Temp 37oC
20 mM Q stock, [Q]f 3 mM 36 0.0
Final Incubate Vol (uL) 720 100
Aliquot Taken (uL) 60 60 60 60 60 60 60 60 Tot FIN vol
4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 360.0
LANE L1 L2 L3 L4 L5 L6 L7 L8 L9 L10
MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
Loading Dye 0 10 10 10 10 10 10 10 10 10
Incub Aliquot of Total 0 15 15 15 15 15 15 15 15 15
Loading Vol (uL) 15 10 10 10 10 10 10 10 10 10
Protein loaded (ug) 9 9 9 9 9 9 9 9 9
in 10%MeOH/buffer
Table B.13. Reaction details of MBQ (1.0 mM) with Lysozyme (0.10 mM) 
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0619 2013 FW mmol mg solution [Q]i [Q]f Incub Vol Q vol
20 mM/50ml stock, MBQ 122.12 0.25 30.53 5 0.5 720 72
Actual MBQ
(uL)Final Lys->0.1 mM mg ml Lys vol 102.1
Stock Lys 0.705 20 2
Freezing time
Total MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
0.705 mM St Lys (uL) 102.1 14.2
Protein (ug) 1035.9 143.9 86.3 86.3 86.3 86.3 86.3 86.3 86.3 86.3
Phosphate buffer (uL) 545.9 85.8
Incub Time 0 min 10 min 30 min 1h 2h 3h 4h 5h 24h
Incub Temp 37oC
20 mM Q stock, [Q]f 3 mM 72 0.0
Final Incubate Vol (uL) 720 100
Aliquot Taken (uL) 60 60 60 60 60 60 60 60 Tot FIN vol
4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 360.0
LANE L1 L2 L3 L4 L5 L6 L7 L8 L9 L10
MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
Loading Dye 0 10 10 10 10 10 10 10 10 10
Incub Aliquot of Total 0 15 15 15 15 15 15 15 15 15
Loading Vol (uL) 15 10 10 10 10 10 10 10 10 10
Protein loaded (ug) 9 9 9 9 9 9 9 9 9
in 10%MeOH/buffer
Table B.14. Reaction details of MBQ (0.50 mM) with Lysozyme (0.10 mM) 
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0619 2013 FW mmol mg solution [Q]i [Q]f Incub Vol Q vol
5 mM/50ml stock, MBQ 122.12 0.25 30.53 5 0.1 720 14.4
Actual MBQ
(uL)Final Lys->0.1 mM mg ml Lys vol 102.1
Stock Lys 0.705 20 2
Freezing time
Total MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
0.705 mM St Lys (uL) 102.1 14.2
Protein (ug) 1035.9 143.9 86.3 86.3 86.3 86.3 86.3 86.3 86.3 86.3
Phosphate buffer (uL) 603.5 85.8
Incub Time 0 min 10 min 30 min 1h 2h 3h 4h 5h 24h
Incub Temp 37oC
20 mM Q stock, [Q]f 3 mM 14.4 0.0
Final Incubate Vol (uL) 720 100
Aliquot Taken (uL) 60 60 60 60 60 60 60 60 Tot FIN vol
4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 4 x 15 360.0
LANE L1 L2 L3 L4 L5 L6 L7 L8 L9 L10
MM Ctr 24h 10 30 1h 2h 3h 4h 5h 24h
Loading Dye 0 10 10 10 10 10 10 10 10 10
Incub Aliquot of Total 0 15 15 15 15 15 15 15 15 15
Loading Vol (uL) 15 10 10 10 10 10 10 10 10 10
Protein loaded (ug) 9 9 9 9 9 9 9 9 9
in 10%MeOH/buffer
Table B.15. Reaction details of MBQ (0.10 mM) with Lysozyme (0.10 mM) 
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